Search Results - "Klonoff, David C."

Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital by Umpierrez, Guillermo E, Klonoff, David C

“…The use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems has gained wide acceptance in diabetes care. These…”
Get full text

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States by Bode, Bruce, Garrett, Valerie, Messler, Jordan, McFarland, Raymie, Crowe, Jennifer, Booth, Robby, Klonoff, David C.

“…Introduction: Diabetes has emerged as an important risk factor for severe illness and death from COVID-19. There is a paucity of information on glycemic…”
Get full text

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia by Bergenstal, Richard M, Klonoff, David C, Garg, Satish K, Bode, Bruce W, Meredith, Melissa, Slover, Robert H, Ahmann, Andrew J, Welsh, John B, Lee, Scott W, Kaufman, Francine R

“…In this study involving patients with type 1 diabetes, sensor-augmented insulin-pump therapy plus automated insulin suspension when glucose dropped below 70 mg…”
Get full text

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors by Klonoff, David C, Parkes, Joan Lee, Kovatchev, Boris P, Kerr, David, Bevier, Wendy C, Brazg, Ronald L, Christiansen, Mark, Bailey, Timothy S, Nichols, James H, Kohn, Michael A

“…Cleared blood glucose monitors (BGMs) for personal use may not always deliver levels of accuracy currently specified by international and U.S. regulatory…”
Get full text

Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries by Meo, Sultan Ayoub, Abukhalaf, Abdulelah Adnan, Alomar, Ali Abdullah, AlMutairi, Faris Jamal, Usmani, Adnan Mahmood, Klonoff, David C

“…This study aimed to assess the impact of 15 days before, 15 days during, and 15 days after the lockdown on the trends in the prevalence and mortality in 27…”
Get full text

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic by Galindo, Rodolfo J., Aleppo, Grazia, Klonoff, David C., Spanakis, Elias K., Agarwal, Shivani, Vellanki, Priya, Olson, Darin E., Umpierrez, Guillermo E., Davis, Georgia M., Pasquel, Francisco J.

“…Continuous glucose monitoring (CGM) has become a widely used tool in the ambulatory setting for monitoring glucose levels, as well as detecting uncontrolled…”
Get full text

Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19 by Meo, Sultan Ayoub, Al-Khlaiwi, Thamir, Usmani, Adnan Mahmood, Meo, Anusha Sultan, Klonoff, David C., Hoang, Thanh D.

“…The novel coronavirus (Covid-19) infection outbreak has posed a major threat to the international health system and economy. This study is aimed at…”
Get full text

Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis by Kerr, David, Ahn, David, Waki, Kayo, Wang, Jing, Breznen, Boris, Klonoff, David C

“…The proliferation of digital technology has the potential to transform diabetes management. One of the critical aspects of modern diabetes management remains…”
Get full text

Evidence-based Mobile Medical Applications in Diabetes by Drincic, Andjela, MD, Prahalad, Priya, MD, PhD, Greenwood, Deborah, PhD, RN, CDE, Klonoff, David C., MD, FRCP (Edin)

“…This article reviews mobile medical applications that are commercially available in the United States or European Union (EU) and are (1) associated with…”
Get full text

Update on Measuring Ketones by Huang, Jingtong, Yeung, Andrea M., Bergenstal, Richard M., Castorino, Kristin, Cengiz, Eda, Dhatariya, Ketan, Niu, Isabella, Sherr, Jennifer L., Umpierrez, Guillermo E., Klonoff, David C.

“…Ketone bodies are an energy substrate produced by the liver and used during states of low carbohydrate availability, such as fasting or prolonged exercise…”
Get full text

The Need for Data Standards and Implementation Policies to Integrate Insulin Delivery Data Into the Electronic Health Record by Espinoza, Juan C., Yeung, Andrea M., Huang, Jingtong, Seley, Jane Jeffrie, Longo, Rebecca, Klonoff, David C.

“…Integration of insulin dosing data into the electronic health record (EHR), combined with other patient-generated health care data, would facilitate the use of…”
Get full text

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) by Bergenstal, Richard M, Ahmann, Andrew J, Bailey, Timothy, Beck, Roy W, Bissen, Joan, Buckingham, Bruce, Deeb, Larry, Dolin, Robert H, Garg, Satish K, Goland, Robin, Hirsch, Irl B, Klonoff, David C, Kruger, Davida F, Matfin, Glenn, Mazze, Roger S, Olson, Beth A, Parkin, Christopher, Peters, Anne, Powers, Margaret A, Rodriguez, Henry, Southerland, Phil, Strock, Ellie S, Tamborlane, William, Wesley, David M

“…Abstract Underutilization of glucose data and lack of easy and standardized glucose data collection, analysis, visualization, and guided clinical decision…”
Get more information

Artificial Intelligence for Predicting and Diagnosing Complications of Diabetes by Huang, Jingtong, Yeung, Andrea M., Armstrong, David G., Battarbee, Ashley N., Cuadros, Jorge, Espinoza, Juan C., Kleinberg, Samantha, Mathioudakis, Nestoras, Swerdlow, Mark A., Klonoff, David C.

“…Artificial intelligence can use real-world data to create models capable of making predictions and medical diagnosis for diabetes and its complications. The…”
Get full text

A Newly FDA-Cleared Benchtop Glucose Analyzer Heralds the Dawn of the Post–YSI 2300 Era by Klonoff, David C., Yeung, Andrea M., Huang, Jingtong, Nichols, James H.

Get full text

Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing by Klonoff, David C, Bassock, Stephanie, Dwyer, Andrea, Engels, Ella, Qvist, Marianne, Sparre, Thomas, Snitker, Soren

“…Aims/Introduction A single‐dose, shield‐activated pen‐injector for each of the three approved dose variants (0.25, 0.5 and 1 mg) of once‐weekly subcutaneous…”
Get full text

Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications and Adverse Effects of JYNNEOS and ACAM2000 Monkeypox Vaccines by Meo, Sultan Ayoub, Al-Masri, Abeer A, Klonoff, David C, Alshahrani, Abdullah Nasser, Al-khlaiwi, Thamir

“…Human monkeypox is an emerging viral zoonotic disease, that has caused highly distinctive, challenging and threatening problems worldwide. The US Food and Drug…”
Get full text

Continuous Glucose Monitoring in the Hospital by Perez-Guzman, M Citlalli, Shang, Trisha, Zhang, Jennifer Y, Jornsay, Donna, Klonoff, David C

“…Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has…”
Get full text

Continuous glucose monitoring: A review of the technology and clinical use by Klonoff, David C., Ahn, David, Drincic, Andjela

“…•RCTs have shown that CGM can reduce A1c and time spent in hypoglycemia.•CGM can help clarify A1c readings that do not match corresponding SMBG records. ​•CGM…”
Get full text

The Diabetes Technology Society Green Diabetes Initiative by Klonoff, David C., Heinemann, Lutz, Cook, Curtiss B., Thompson, Bithika M., Kerr, David, Han, Julia, Krisiunas, Edward P.

Get full text

Digital Health Interventions for Diabetes: Everything to Gain and Nothing to Lose by Kerr, David, King, Fraya, Klonoff, David C

“…The traditional approach to integrating new therapies involves long, expensive roadmaps with evidence generation required for multiple stakeholders, most…”
Get full text